AllStripes
A research platform designed for rare diseases, where patients can contribute to research and accelerate drug development.
Launch date
Employees
Market cap
-
Enterprise valuation
€182—273m (Dealroom.co estimates Aug 2021.)
San Francisco California (HQ)
Financials
Estimates*
| EUR | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | <1m | 3.0m | 11.8m | 12.2m | 12.2m |
| % growth | - | 230 % | 293 % | 3 % | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Seed | ||
$3.1m | Seed | ||
$14.0m | Series A | ||
$50.0m | Series B | ||
* | N/A | Acquisition | |
| Total Funding | €61.0m | ||
Related Content
Recent News about AllStripes
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.